Fig. 8From: Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patientsProfile of γδ1 and γδ2 T cell expression of receptors and adhesion molecules in control, moderate CFS/ME and severe CFS/ME patients. a γδ1 T cells with the expression CD94−CD11a−, as a number of total γδ1 T cells (cells/μL). b γδ2 T cells with the expression CD94−CD11a−, as a total number of γδ2 T cells (cells/μL). c γδ2 T cells with the expression CD94−CD11a+, as a total number of γδ2 T cells (cells/μL). d γδ1 T cells expressing CD62L+CD11a− as a total number of γδ1 T cells (cells/μL). e γδ2 T cells expressing CD62L+CD11a−, as a total number of γδ2 T cells (cells/μL). f γδ2 T cells with the expression CD62L+CD11a+, as a total number of γδ2 T cells (cells/μL). Data is shown as mean ± SEM where statistical significance was accepted as p < 0.05. CFS/ME Chronic Fatigue Syndrome/Myalgic Encephalomyelitis, SEM standard error of the meanBack to article page